We have known about Truvada for a while. Now, an influential advisory panel of the Food and Drug Administration has endorsed the drug shown to prevent HIV infection in healthy people. It recommended approval of the pill for people at risk of contracting the virus. A final decision is expected next month, but if FDA does approve, it won’t be without a degree of controversy. We’re joined by Dr. Kenneth Mayer, medical research director at Fenway Health in Boston and a professor at Harvard Medical School.
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!